Prostate Cancer: Is AI the Answer to Limit Need of Biopsies?
A retrospective study shows that combining risk markers, MRI evaluation, and AI can more accurately predict prostate cancer risk.
Read MorePosted by Chris Wolski | Aug 6, 2024 | Prostate |
A retrospective study shows that combining risk markers, MRI evaluation, and AI can more accurately predict prostate cancer risk.
Read MorePosted by Andy Lundin | Jul 23, 2024 | Prostate |
A prostate cancer test using protein and genetic markers improves diagnosis accuracy and reduces unnecessary procedures across ethnic groups.
Read MorePosted by Andy Lundin | Jul 1, 2024 | Prostate |
A study warns that transgender women on hormone therapy may have artificially low PSA levels, potentially delaying prostate cancer diagnosis.
Read MorePosted by Andy Lundin | Apr 18, 2024 | Prostate |
The new urine-based test aims to differentiate between slow-growing and aggressive forms of prostate cancer.
Read MorePosted by Chris Wolski | Apr 15, 2024 | Prostate |
A study found an active surveillance blood test for prostate cancer could predict whether a patient had indolent or aggressive disease.
Read More